MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20243749

May 21, 2024

Drug Information

盐酸奥洛他定滴眼液

眼用制剂

0.1% (5ml:5mg, 按C₂₁H₂₃NO₃计)

化学药品

May 21, 2024

Company Information

Applicant Company

辽宁省沈阳市沈北新区蒲南路158号

Manufacturing Company

沈阳市沈北新区辉山经济开发区沈北路176号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.